{"name":"Inversago Pharma Inc.","slug":"inversago-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"INV-202","genericName":"INV-202","slug":"inv-202","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"INV-202","genericName":"INV-202","slug":"inv-202","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1nQ212S2t2cVpTMVd2YWNSY0Q2ellNWUdHTzBxMG0wUF85NTZFMmI2SkRnTmtTQXNXcnc0b2QxbHF3WnE0eWVYd3phQTBReXpwZVFB?oc=5","date":"2025-08-06","type":"pipeline","source":"FirstWord Pharma","summary":"Pipeline cleanout greets new Novo CEO - FirstWord Pharma","headline":"Pipeline cleanout greets new Novo CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPSW44M3ZlclpTajd1UFZFc3JRVmwzLUtEcTVfQm9COC1vcTBYdUVCa0pSZExZdjI0ak53LU44SFRCMVNnMmlEd0FUbDRsVUE4bDNWMlJLUTVBQndNUWFEdkNuRnpILTBpU0xNNVNaYU12eThxZ1g1eTB6aEVxUFgtUjhUcUtOYmhLS1R3VVFkZ2VsdmppQmFLQUUxVU9tam5haXFiWkdNQk9jZEcxcnBmVzlXdGIwX0ItMUFBM2FSTjVqbVI2ZDZUSEdVUnhTejZ3Ry1xQy1vd1lRWmdHS3JZQWVZT1ViTXhNYjlF?oc=5","date":"2025-05-05","type":"trial","source":"Business Wire","summary":"François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth - Business Wire","headline":"François Ravenelle, PhD Appointed President and CEO of Innospera Pharma to Lead Next Phase of Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNd1NUM2RQclZWSEVVUC1xV0JCNVF2X3RiVGNpZ3lkd0JNYjMyVVdJa1Q3MF9wRXViUHdDdVQwWWhsTm14eHAyclJmVFhKaVRMajNTV2VHc1Z2bDFlVS1rSmlxcjdhQml3Z1U5N2ptNWJhcEFmR1lxX3l4d19KSV9xd0FlRVNfWTlIR2Z3aUpR?oc=5","date":"2023-08-14","type":"pipeline","source":"Pharmaceutical Executive","summary":"Novo Nordisk Announces Acquisition of Inversago Pharma - Pharmaceutical Executive","headline":"Novo Nordisk Announces Acquisition of Inversago Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNZF9yNk90emszdTRyQ25TcGlnYXNLSkNoazVCS0RqalBSQVZYVDh0VlRvZVJoOG9pdlRyb3k3SGwzZkg3aDlwTmFGeVFSV3laTnFLczFaNDBoQ014Q0hIT19wWTlMb3JlOXJFOTRDLUtqYnliM1FOdEtXSEE4bUxpdXlNSjdtWXlBZXc5OXJlR05LNnFJNUJr?oc=5","date":"2023-08-11","type":"pipeline","source":"European Biotechnology Magazine","summary":"Novo Nordisk takes over Inversago Pharma Inc. - European Biotechnology Magazine","headline":"Novo Nordisk takes over Inversago Pharma Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxPYUZCZ3pSZFJaRk43Y3gwcG80STY3aG8tLXBuZk5iaXgyc09tMW5RWjY1YnBjSWZJaWM5MFhtVG9YQXViWTVaXzBDM1BDeHpERjYxVDIyTWdaNnZMamw2Q2duUnlod2JQU21pR210X2ZjY0h5TkJRcHpBZVZJVW9WbDJyTzhZall6UzljMVpmd1BXQUZFbTBUbjNMV2d0ejB4NUdzN1FuUC1JdFlWUUxvSWhwWlNWejNnaEhFWFU3cFdXS0FFd0NqcGZpZHpwZGRQODdfOFlHa0hsMnU5OG9MMmc4eHFrSG5kTWxuaE02TmEweVJPT3JVZU53TmlOY2U3aU91RDZ5NTdmckxTZVZNOWg5eHdmMTVZZDA0SDJhNFIxZWV5RlNKRzFYNUo1RTVUTndObUgtVFBEdw?oc=5","date":"2023-08-10","type":"deal","source":"GlobeNewswire","summary":"Novo Nordisk to acquire Inversago Pharma to develop new - GlobeNewswire","headline":"Novo Nordisk to acquire Inversago Pharma to develop new","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPWF95RmdwRWZrRmVvdjZWYzE2Q2ZLd2F5Z29xOEU0Si1pRVJzaWJlQVo1dzZZSWJRUVdQMVU0d3dmU1ZsZ0xOVFVSXzUyclI4NUxaeEV2eEt0R2dVNllTb0Vwc3N6YnVSR1ZyQk5NSUNsVmJ1SlgxTC1BVWtTVDc1RWdaa052dTJpb3FmUkdjYkluWGk4eEIzZEhUeUZMU0hyTHQ5THdB?oc=5","date":"2023-08-10","type":"deal","source":"Reuters","summary":"Novo Nordisk to acquire obesity drug developer Inversago - Reuters","headline":"Novo Nordisk to acquire obesity drug developer Inversago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNc2FzQUFfcWctUlRpTEhCQ1JoODNjT3JSWWpwVE14dUFLRjRhVmd4dlkzLUZsQUQ2aVFwalF5NFlHTVpDaW9CUmJhVmhoSjF3SGtzeE84Q0staU10c0xzU3FydzdVSUZmOUlqcWxyaVpaUTF2Z0kxcUlibVJnel9SdElNX0ItMzhFSmc?oc=5","date":"2023-08-10","type":"deal","source":"Pharmaceutical Technology","summary":"Novo Nordisk spends $1bn to acquire weight loss drug developer Inversago - Pharmaceutical Technology","headline":"Novo Nordisk spends $1bn to acquire weight loss drug developer Inversago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOT2NRSEhUSVR3YW5TWEVDTHh5TWJMNzB5RWkyeWRmMTBZOGFxczRyOFJrWm1QQlV6MThVRUUyNEU3RFV4WmlodlZ2WmlRbVpGdTVVMzlEWXFENHI2NXlGbnhDTHUzdGc3OGlSdXBCTVRENGpBd0pSZFRyNGV3LVlUVGdaOVh1SGd2OHh5NzdqTjh6YUxMc3h1enFabUxzMFB0eVdYUmhOOEVFUEpm?oc=5","date":"2023-08-10","type":"pipeline","source":"European Pharmaceutical Review","summary":"Novo Nordisk makes $1 billion acquisition agreement - European Pharmaceutical Review","headline":"Novo Nordisk makes $1 billion acquisition agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNQldVZHg0WjVqYktEcTJwY19RX3NhRThZZjNUQ1dpM202Zl8yeF9ta2gyTHdjOWR2WkJpbGlNNVBIQlJmQzFaOEM2ZzBCNk9Hd1dSVDBRVnZrSjVKbHpFRFpSUWR6dU9wSUwzMHJZcXhveUJnbVRTX0NJSm9lMTdSakwyR1ktaVVXbVRpcXlGN2h0WUh0ZjZOX21zc1VKeFdQd29tTkd2ZE9NY2xJaldTYk02TUsyQQ?oc=5","date":"2023-08-10","type":"deal","source":"BioWorld News","summary":"Novo Nordisk targets CB1 for obesity with potential $1B+ buyout of Inversago - BioWorld News","headline":"Novo Nordisk targets CB1 for obesity with potential $1B+ buyout of Inversago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOZXhwdDN3ajdaMkFpMW9hdVRndC1YZGt2UTlBd2FmR1kxbm8zRm03Q0tUMldVSmQ1aHRHX29ZbHI1dzNvcWVrVDZxZmNDODZIOTRkbEJZSTBCZGdEQ1VLVjZzNnBxVF95Q0hXLURuRjBreHhCWi1qSzJKNmh2ZURqSHItRFBPQ1BNRkZr?oc=5","date":"2023-08-10","type":"deal","source":"BioPharma Dive","summary":"Novo adds another obesity drug in $1B deal for startup Inversago - BioPharma Dive","headline":"Novo adds another obesity drug in $1B deal for startup Inversago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOeGRIMGxneTk4aVBsUkhSS09wTGhXYVhHR0h2YXVaUDh5WUJMNW9lcXN0TjFqSm0tQXJGbXdKcExON1lHZWl2RERuSHNrX1ZxbGliUWxrTGtIcDRoUW0tZlZzb1JtdU1kbG9kYzZaQ25GQXlNS3d6T0RpVWQ2UDh4aVlnTE1OM1hUc0xDRVZtZHV0MFRCVnllUEhJUTJaTzVyN2Q5Q2dBQ0QtWFdpcXY5dlVkYWVaUUNaM2ZWN2lnSFhsZ2pzeTVJTQ?oc=5","date":"2023-08-10","type":"deal","source":"roi-nj.com","summary":"Novo Nordisk to acquire Inversago Pharma and its obesity drug development for $1.07B - roi-nj.com","headline":"Novo Nordisk to acquire Inversago Pharma and its obesity drug development for $1.07B - roi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOV0xfSXZ5Slc5aS1QWVp5OWNiVDJ2QmJLVUpxbGVlSy1NU3VDZlU5QzIxOWZYR3JNcUU1a2JhRmlEQlBpQllLejJuVHdTUkY5RXFVZG9ZNHdBdHhqaVRHRElIZ0ZIR3R0MWRjU0xrQV9MM05QTUNaNjZSbGNuNGM1YUpVVjZQZWtneVM5WDNHR2NaQQ?oc=5","date":"2023-08-10","type":"deal","source":"Financial Post","summary":"Montreal biotech with 'promising' weight-loss drug acquired by Ozempic maker - Financial Post","headline":"Montreal biotech with 'promising' weight-loss drug acquired by Ozempic maker","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}